Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMRI6YT)

Drug Name	BI 836880 DMRI6YT
Drug Type	Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Neoplasm	DISZKGEW	2A00-2F9Z	Phase 1	[1]
Wet age-related macular degeneration	DISZBO2J	9B78.3Z	Phase 1	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03972150) A Study to Find the Best Dose of BI 836880 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer. U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT03861234) A Study to Test Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD). U.S. National Institutes of Health.